EFFICACY AND SAFETY OF UPADACITINIB MAINTENANCE THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE: FINAL RESULTS FROM THE PHASE 3 U-ENDURE STUDY

Miguel Regueiro  1     Scott Lee  2     Raja Atreya  3     Efrat Broide  4     Cristina Rodriguez  5     Adriaan A. Van Bodegraven  6     Elena Dubcenco  7     Ana Paula Machado De Lacerda  7     Jianzhong Liu  7     Tian Feng  7     Ziqian Geng  7     Valencia Remple  7     Samuel Anyanwu  7     Julian Panés  8    
1 Cleveland Clinic, Cleveland, United States
2 University of Washington Medical Center, Seattle, United States
3 Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany
4 The Kamila Gonczarowski Institute of Gastroenterology and Liver Diseases, Assaf Harofeh Medical Center, Zerifin, Israel
5 University Hospital of Navarra, Pamplona, Spain
6 Zuyderland Medical Center, Herleen, Sittard-Geleen, Netherlands
7 AbbVie Inc., North Chicago, United States
8 Hospital Clinic Barcelona, IDIPABS, CIBERehd, Barcelona, Spain

Topic
IBD

Conference
UEG Week Copenhagen 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing